Gilde Healthcare Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Gilde Healthcare has acquired 7 companies. It has also invested in 1 other.

Gilde Healthcare’s most common sectors for investment arelife science (49%) and medical products (26%) . The Firm’s most common investment types include venture (66%) and buyout (lbo, mbo, mbi) (18%). In total, Gilde Healthcare has invested in 4 US states and 11 different countries.

In the last 3 years, Gilde Healthcare has exited 4 companies. The Firm’s most common exit type is trade sale (50%). Gilde Healthcare’s largest (disclosed) exit occurred in 2014 when it sold Santaris Pharma A/S for $250M.

Join Mergr to view Gilde Healthcare’s full profile and discover more middle-market private equity firm investors just like it.

M&A Summary

  • M&A Total Activity77
    • M&A Buy Activity47
    • M&A Sell Activity30
  • Total Sectors Invested 10
  • Total Countries Invested 11
  • M&A Buy/Sell Connections 30
  • M&A Advisors 5

Gilde Healthcare

Stadsplateau 36,
Utrecht, 3521 AZ
Netherlands
31 30 219 25 65
www.gildehealthcare.com
healthcare@gildehealthcare.com

Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest up to €30 million in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 2001 and is headquartered in Utrecht, the Netherlands.


Investment Criteria

Sectors of Interest: Consumer Services, Healthcare Services, Information Technology, Life Science, Medical Products, Test/Measurement Equipment

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Nordic

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA 1 10
Investment Size - 30
Enterprise Value - 75
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.6/yr) # 39 - 3 4 1 - 47
Sell (1.0/yr) # 25 1 3 - 1 - 30
vol $1.6B $231M $1.9B
  77

Most Recent M&A

Company Date Value Type
Swiss Dental Solutions AG 2023-12-18 - Buyout (LBO, MBO, MBI)
Kreuzlingen, Switzerland · www.swissdentalsolutions.com
Zetacom B.V. 2023-02-15 - Secondary Sale
Zoetermeer, Netherlands · www.zetacom.nl
Sanquin Reagents BV 2022-08-29 - Divestiture
Amsterdam, Netherlands
Chr. Diener GmbH & Co. KG 2022-07-05 - Buyout (LBO, MBO, MBI)
Tuttlingen, Germany · www.diener-gmbh.de
SpliceBio SL 2022-02-16 - Venture
Barcelona, Spain · www.splice.bio
EUROPIN Ltd. 2022-02-10 - Buyout (LBO, MBO, MBI)
Trencianske Stankovce, Slovakia · www.europin.sk
Vesper Medical, Inc. 2021-12-14 - Trade Sale
Wayne, Pennsylvania · www.vespermedical.com
DETAX GmbH & Co. KG 2021-12-03 - Buyout (LBO, MBO, MBI)
Ettlingen, Germany · www.detax.de
Laboratoris Sanifit S.L. 2021-11-22 231M EUR Trade Sale
Palma de Mallorca, Spain · www.sanifit.com
Symeres 2021-05-25 - Secondary Sale
Groningen, Netherlands · www.symeres.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 7 (39%) - 23 (49%) -
Medical Products 6 (33%) - 12 (26%) -
Healthcare Services 1 (6%) - 3 (6%) -
Information Technology 1 (6%) - 3 (6%) -
Business Services 1 (6%) - 1 (2%) -
Consumer Services - - 1 (2%) -
Food 1 (6%) - 1 (2%) -
Manufacturing 1 (6%) - 1 (2%) -
Staffing - - 1 (2%) -
Test/Measurement Equipment - - 1 (2%) -
Total 18 - 47 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
Netherlands 5 (28%) - 14 (30%) -
United States 2 (11%) - 8 (17%) -
  California 1 (6%) - 4 (9%) -
  Massachusetts - - 2 (4%) -
  New Hampshire 1 (6%) - 1 (2%) -
Germany 3 (17%) - 6 (13%) -
United Kingdom 2 (11%) - 5 (11%) -
Denmark 1 (6%) - 4 (9%) -
Spain 1 (6%) - 3 (6%) -
Switzerland 1 (6%) - 2 (4%) -
Belgium - - 2 (4%) -
France 1 (6%) - 1 (2%) -
Ireland 1 (6%) - 1 (2%) -
Slovakia 1 (6%) - 1 (2%) -
Total 18 - 47 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 8 (44%) - 31 (66%) -
Buyout (LBO, MBO, MBI) 6 (33%) - 8 (17%) -
Growth Capital 2 (11%) - 5 (11%) -
Secondary Buyout 1 (6%) - 2 (4%) -
Divestiture 1 (6%) - 1 (2%) -
Total 18 - 47 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 12 (40%) 1.7B (92%)
IPO 9 (30%) -
Secondary Sale 5 (17%) -
Trade Sale 4 (13%) 150M (8%)
Total 30 $1.9B

Top M&A Advisors

Financial Deals
GCA Altium Ltd.
1
William Blair
1
PwC Corporate Finance LLC
1
Legal Deals
King & Wood Mallesons
1
Shearman & Sterling
1

Deal Values

sell # Total
$100M to $1B 9 $1.8B
< $100M 1 $80M
TOTAL $1.9B
Largest Santaris Pharma A/S
$250M (2014-08-06)

M&A Connections

Deals
Acquired from
Investor(s)
4%
2 (4%)
Strategic(s)
2%
1 (2%)
Exited to
Investor(s)
17%
5 (17%)
Strategic(s)
50%
15 (50%)

FAQ

When was Gilde Healthcare founded?

Gilde Healthcare was founded in 1999.

What type of investor is Gilde Healthcare?

Gilde Healthcare is a private equity firm.

Where is Gilde Healthcare headquartered?

Gilde Healthcare is headquartered in Utrecht, Netherlands.

How much capital does Gilde Healthcare have under management?

Gilde Healthcare has 800M EUR under management.

 Subscribe to unlock this and 201,199
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 192K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.